跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Xipro - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Xipro
Approved
STANDARD
Xipro
Drugmaker's laboratories, Inc
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
020ba22b030cd8b2
Company
Drugmaker's laboratories, Inc
Type
Standard
Approval Details
Approval Id
020ba22b030cd8b2
Drug Approval Philippines Name
Xipro
Product Name
Xipro
Registration Number
DRP-794
Brand Name
Xipro
Generic Name
Ciprofloxacin (as hydrochloride)
Dosage Form
Film-Coated Tablet
Dosage Strength
500 mg
Manufacturer
Drugmaker's laboratories, Inc
Trader
Terramedic,Inc.
Issuance Date
25 March 2024
Expiry Date
20 August 2025
Pharmacologic Category
Antibacterial (Fluoroquinolone)
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
020ba22b030cd8b2
Type
Standard
Back to Philippines FDA Approvals